GeoVax Labs, Inc. (NASDAQ:GOVX – Get Free Report) saw a significant growth in short interest in August. As of August 31st, there was short interest totalling 794,700 shares, a growth of 17.1% from the August 15th total of 678,900 shares. Based on an average trading volume of 396,700 shares, the short-interest ratio is presently 2.0 days.
Analysts Set New Price Targets
Separately, HC Wainwright restated a “buy” rating and set a $8.00 target price on shares of GeoVax Labs in a report on Thursday, August 31st.
Hedge Funds Weigh In On GeoVax Labs
GeoVax Labs Stock Performance
Shares of GOVX stock opened at $0.54 on Tuesday. The company has a fifty day moving average price of $0.57 and a two-hundred day moving average price of $0.62. GeoVax Labs has a one year low of $0.51 and a one year high of $1.39.
GeoVax Labs (NASDAQ:GOVX – Get Free Report) last issued its quarterly earnings data on Wednesday, August 9th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.16) by ($0.06). On average, research analysts expect that GeoVax Labs will post -0.64 EPS for the current year.
About GeoVax Labs
GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers.
- Five stocks we like better than GeoVax Labs
- What are stock market earnings reports?
- 2 Beauty Stocks Beaten By the Ugly Stick But Ready to Rally
- What is the NASDAQ Stock Exchange?
- Got Nuclear? Three Stocks To Play Energy’s Next Frontier
- Want to Profit on the Downtrend? Downtrends, Explained.
- The Top 4 Utilities for Value, Yield, and Upside Potential
Receive News & Ratings for GeoVax Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoVax Labs and related companies with MarketBeat.com's FREE daily email newsletter.